NCT02723734View on ClinicalTrials.gov

Validation Study on the Impact of Decipher® Testing - VANDAAM Study

Active, not recruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

April 13, 2016

Primary Completion Date

July 6, 2023

Study Completion Date

October 31, 2025

Conditions
Prostate Cancer
Interventions
OTHER

Decipher® Testing

Decipher® Prostate Cancer Classifier (Post-Op and Biopsy), a Genomic Classifier (GC) test. Biopsy and prostatectomy specimens will be collected for GC testing.

Trial Locations (3)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

James A. Haley VA Hospital, Tampa

33744

Bay Pines VA Health care System, Bay Pines

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT02723734 - Validation Study on the Impact of Decipher® Testing - VANDAAM Study | Biotech Hunter | Biotech Hunter